Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin.
about
Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infectionsOritavancin for acute bacterial skin and skin structure infections.Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisAntibacterial responses of retinal Müller glia: production of antimicrobial peptides, oxidative burst and phagocytosis.Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.Oritavancin: A Long-Half-Life Lipoglycopeptide.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.Study of macrophage functions in murine J774 cells and human activated THP-1 cells exposed to oritavancin, a lipoglycopeptide with high cellular accumulation.Oritavancin Pharmacokinetics and Bone Penetration in Rabbits.Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.Oritavancin (Orbactiv): A New-Generation Lipoglycopeptide for the Treatment Of Acute Bacterial Skin and Skin Structure Infections.Influence of the protein kinase C activator phorbol myristate acetate on the intracellular activity of antibiotics against hemin- and menadione-auxotrophic small-colony variant mutants of Staphylococcus aureus and their wild-type parental strain in h
P2860
Q26799701-29916DED-1231-43B6-AAF9-BAFC0A7E750BQ36086423-E3ED153D-FC9F-47B5-B915-43FD27C2BFE7Q36457770-B35FCF6A-845F-4D77-B3BE-0EB21CB86BB5Q37607511-07A31943-978E-4588-B06C-09B1C04781C4Q38233471-11C92F2B-7486-4E8F-892F-77AA68937059Q38434265-71D3647A-F245-4978-BD97-EBAFA7A5F02CQ38646905-B55914DB-11B1-40E2-92AF-AC70D94743B0Q39031976-382988ED-9AD4-4971-BFDF-0C67F2673E08Q41073732-2B5D2062-6B66-4CAB-A9A3-6265C9CF3823Q43563522-9770FB99-3DA5-483E-AD19-BB5D34CA2A95Q52680606-D13C194A-FCC1-4F91-8FFC-CD175DB22B2BQ58573611-E328FE36-8211-4FFB-9063-159160FCC729
P2860
Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Macrophage killing of bacteria ...... eptide antibiotic oritavancin.
@en
Macrophage killing of bacteria ...... eptide antibiotic oritavancin.
@nl
type
label
Macrophage killing of bacteria ...... eptide antibiotic oritavancin.
@en
Macrophage killing of bacteria ...... eptide antibiotic oritavancin.
@nl
prefLabel
Macrophage killing of bacteria ...... eptide antibiotic oritavancin.
@en
Macrophage killing of bacteria ...... eptide antibiotic oritavancin.
@nl
P2093
P2860
P356
P1476
Macrophage killing of bacteria ...... eptide antibiotic oritavancin.
@en
P2093
Beverlie Baquir
Brad Spellberg
Sandrine Lemaire
P2860
P304
P356
10.1093/CID/CIR921
P407
P478
54 Suppl 3
P577
2012-04-01T00:00:00Z